The abundance of biochemical and structural knowledge on the Cyclin-Dependent Kinases (CDKs) has provided a comprehensive but not exhaustive insight into the molecular determinants that govern their function mechanisms. The implementation of structural and functional CDK models towards developing novel anticancer strategies that will specifi cally target individual or multiple CDKs remains a critical need. More than 250 CDKs crystal structures are available to-date, including truncated or whole, modifi ed or not, active or inactive forms, co-crystallized with the cyclins and/or their respective putative inhibitors, though, to our knowledge, there is no NMR solved structure available to date. We hitherto attempt to provide a useful guide from protein production to crystallization for CDK/Inhibitors complexes based on an overview of the already elucidated CDK structures, constructs and the preferable expression vectors in each case, in order to yield the respective crystals.
CITATION STYLE
Grigoroudis, A. I., & Kontopidis, G. (2016). Preparation of CDK/cyclin inhibitor complexes for structural determination. Methods in Molecular Biology, 1336, 29–45. https://doi.org/10.1007/978-1-4939-2926-9_4
Mendeley helps you to discover research relevant for your work.